Christopher Hourigan C, Dillon L, Logan B, et al. Impact of conditioning intensity of allogenic transplantation for acute myeloid leukemia with genomic evidence of residual disease. 24th Congress of EHA, abstract LB2600.
Pembrolizumab wordt per 1 juli vergoed
jul 2017 | Lymfoom